AGT-194

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAGT-194

Drug Alias NameHIRMAb-PPT1 fusion protein (ArmaGen)AGT-194

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionPalmitoyl-protein thioesterase 1 modulatorsInsulin receptor inhibitors

TargetsPalmitoyl-protein thioesterase 1Insulin receptor

Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArmagen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArmagen Inc

Active IndicationsN/A

Inactive IndicationsNeuronal Ceroid-Lipofuscinoses

Other Information

ATC CodeN/A